Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Why Yext (YEXT) Stock Is Down Today

December 10, 2024 at 12:24 PM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

YEXT Cover Image

What Happened?

Shares of online reputation and search platform Yext (NYSE: YEXT) fell 17.9% in the morning session after the company reported underwhelming third-quarter results. The company did not raise full-year guidance in line with the beats. This implies that the company's expectations for Q4 are below Wall Street's estimates.

On the other hand, Yext blew past analysts' billings expectations. Its EBITDA also outperformed Wall Street's estimates. Zooming out, we think this was a good quarter with some questions about guidance mechanics. The areas below expectations seem to be driving the move.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Yext? Access our full analysis report here, it’s free.

What The Market Is Telling Us

Yext’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. But moves this big are rare even for Yext and indicate this news significantly impacted the market’s perception of the business.

The biggest move we wrote about over the last year was 9 months ago when the stock gained 24.2% on the news that the company reported strong fourth-quarter results with revenue exceeding expectations by a narrow margin, though EPS came in well ahead of Wall Street's estimates. Yext produced $14.8 million of adjusted EBITDA (vs estimates of $12.6 million), partly thanks to a significant year-on-year increase in its gross margin, which expanded from 74% to 78.6% thanks to the company's shift to a professional services strategy. This encouraging gross margin expansion trumped its underwhelming full-year revenue guidance, which was below expectations. A reason for the lower revenue guidance was the loss of a large customer during the quarter, but the market doesn't seem to care. Overall, it was a decent quarter for Yext.

Yext is up 21.8% since the beginning of the year, but at $7.08 per share, it is still trading 17.7% below its 52-week high of $8.60 from December 2024. Investors who bought $1,000 worth of Yext’s shares 5 years ago would now be looking at an investment worth $516.05.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article